HypoglycemiaHyperglycemiaBlood GlucoseInsulinDiabetic KetoacidosisInsulin ComaHypoglycemic AgentsDiabetes Mellitus, Type 1Diabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Hemoglobin A, GlycosylatedInsulin, Long-ActingDiabetes MellitusInsulin Infusion SystemsIslets of LangerhansBlood Glucose Self-MonitoringGlucagonGlucoseHyperinsulinismInsulin, Regular, PorkInsulin LisproGliclazideInfusions, SubcutaneousCongenital HyperinsulinismSulfonylurea CompoundsInsulin, IsophaneGlucose Clamp TechniquePostoperative ComplicationsEpinephrineInsulin AntibodiesRetrospective StudiesTreatment OutcomeCritical IllnessPancreatic PolypeptideDiabetic AngiopathiesRisk FactorsAwarenessTime FactorsC-PeptideGlucose Tolerance TestStreptozocinIslets of Langerhans TransplantationComaMetforminSeverity of Illness IndexClinical AlarmsDiabetes ComplicationsGluconeogenesisFastingDrug Administration ScheduleVentromedial Hypothalamic NucleusRats, Sprague-DawleyInjections, SubcutaneousBrain DiseasesSeizuresFollow-Up StudiesPostprandial PeriodIncidenceNesidioblastosisProspective StudiesCognitionHydrocortisoneBrainInsulinomaInsulin-Secreting CellsPancreas, ArtificialGlipizideInsulin ResistanceGlucokinasePregnancy in DiabeticsNorepinephrineFatty Acids, NonesterifiedHomeostasisLiverGlucagon-Like Peptide 1Diazoxide3-Hydroxybutyric AcidGlycosuriaPancreatectomyGermanyPancreasInfusions, IntravenousDiabetic NeuropathiesInfant, NewbornInsulin AspartPhlorhizinMonitoring, AmbulatoryReference ValuesDiabetic NephropathiesCognition DisordersDipeptidyl-Peptidase IV InhibitorsBody WeightIntraoperative ComplicationsHuman Growth HormoneLactic AcidCardiovascular DiseasesDiabetic ComaLactatesIntervention StudiesGlucagon-Secreting Cells